Thymosin Alpha-1 10mg

Choosing a supplier for Thymosin Alpha-1 10mg research comes down to reproducibility: the same sequence, the same purity profile and the same handling documentation on every order. The Thymosin Alpha-1 10mg offered here is a lyophilised research powder, tested by an independent laboratory using HPLC-MS and released with a batch-matched purity report, so the analytical data you review belongs to the material in your vial.

Thymosin alpha-1 is a synthetic 28-amino-acid peptide corresponding to the N-terminal fragment of prothymosin alpha, with an acetyl group on the N-terminus. It is one of the most extensively investigated immunomodulatory peptides and is used in research on T-cell function, innate immunity and vaccine-adjuvant behaviour. Because the lyophilised format removes water from the preparation, the powder is stable during transport and can be stored frozen for extended periods before it is reconstituted for experimental work.

Thymosin Alpha-1 10mg Key Takeaways

• Compound class: synthetic N-acetylated 28-amino-acid peptide (prothymosin alpha fragment).
• Format: lyophilised research powder in a sealed glass vial.
• Vial sizes: 10mg.
• Purity: 99% (HPLC-MS verified, third-party tested).
• Price: $105 per vial.
• Fulfilment: domestic US shipping with a batch certificate of analysis.
• Status: for laboratory research use only; not for human or veterinary use.

Table of Contents

1. What Is Thymosin Alpha-1 10mg?
2. Thymosin Alpha-1 10mg Specifications
3. Research Overview
4. Reported Mechanism of Action
5. Purity, Testing and Certificates of Analysis
6. Handling, Storage and Reconstitution
7. Available Sizes and Pricing
8. How to Order Thymosin Alpha-1 10mg Online
9. Frequently Asked Questions
10. Related Research Peptides
11. References and Further Reading

What Is Thymosin Alpha-1 10mg?

Thymosin Alpha-1 10mg is one of the synthetic N-acetylated 28-amino-acid peptide (prothymosin alpha fragment) entries in the Protide Health Lab research catalogue. It is released for sale only after independent identity confirmation by mass spectrometry and purity measurement by HPLC, and the resulting report is stored against the batch number printed on the vial.

Also known as: Thymosin Alpha-1, Thymalfasin, N-acetyl prothymosin alpha fragment.

Nothing in this catalogue is presented as a treatment or a supplement. What the documentation does establish is that Thymosin Alpha-1 10mg is the sequence it claims to be, at the purity reported, in the vial that was shipped to you – which is the part of a peptide purchase that can actually be verified.

Thymosin Alpha-1 10mg Specifications

Property	Details
Product Contents	Thymosin Alpha-1 10mg Lyophilized Powder (99% purity) in 3mL vial.
Available Sizes	10mg
Peptide Type	Synthetic N-acetylated 28-amino acid peptide (prothymosin alpha fragment)
Purity	99% (HPLC-MS verified, third-party tested)
Molecular Formula	C 129 H 215 N 33 O 55
Molecular Weight	3108.32 g/mol
Sequence	Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn
CAS Number	62304-98-7
CID	16130571
Synonyms	TA1, Thymosin α1
Appearance	White to off-white lyophilized powder
Storage	Store at ≤6°C, sealed, away from heat, light, and moisture.
Solubility	Soluble in water

Reference values are provided for laboratory identification and comparison purposes. Where a molecular formula, sequence or identifier is listed, it reflects the compound as it is supplied and should be cross-checked against your own internal specification before use.

Research Overview: T-cell maturation and proliferation assays

Published investigation of Thymosin Alpha-1 10mg treats it as a synthetic N-acetylated 28-amino-acid peptide (prothymosin alpha fragment) and concentrates on mechanistic questions rather than clinical outcomes. The sections that follow summarise those areas so that a researcher can see where the compound has been studied. For anyone looking to buy thymosin alpha 1 online, Protide Health Lab keeps the decision simple by attaching the analytical record for the specific batch to the product page and to the shipment.

T-cell maturation and proliferation assays

In T-cell maturation and proliferation assays, published work typically examines Thymosin Alpha-1 10mg from the perspective of signalling cross-talk between converging pathways. Because these endpoints are measured in controlled culture systems, results are usually reported against a vehicle control and a reference compound, which allows the contribution of the peptide itself to be separated from assay variability. For a laboratory working in this field, the practical requirement is a peptide whose sequence identity and purity have been independently confirmed.

Dendritic-cell and TLR signalling research

Research interest in Dendritic-cell and TLR signalling research centres on how Thymosin Alpha-1 10mg behaves at the level of dose-dependent changes in cellular readouts. Reported findings in this area are most useful when the preparation is fully characterised, since an unquantified purity difference between batches can easily be mistaken for a biological effect. This is one of the clearest reasons to insist on batch-level analytical documentation before designing an experiment.

Natural killer cell activity

Within Natural killer cell activity, investigators use Thymosin Alpha-1 10mg to probe receptor occupancy and downstream second-messenger activity. The literature in this area is not uniform: study designs differ in concentration range, exposure time and model system, so comparisons across papers should be made with attention to those parameters. Reproducibility in this line of work depends heavily on the consistency of the starting material across repeats.

Th1/Th2 cytokine balance studies

Studies grouped under Th1/Th2 cytokine balance studies generally treat Thymosin Alpha-1 10mg as a tool for examining gene-expression shifts and protein-level endpoints. Endpoints here are typically quantitative – fluorescence, luminescence, chromatographic signal or imaging counts – which makes reproducible material quality a practical requirement rather than a formality. For a laboratory working in this field, the practical requirement is a peptide whose sequence identity and purity have been independently confirmed.

Vaccine adjuvant research

In Vaccine adjuvant research, published work typically examines Thymosin Alpha-1 10mg from the perspective of enzyme kinetics and substrate handling. Because these endpoints are measured in controlled culture systems, results are usually reported against a vehicle control and a reference compound, which allows the contribution of the peptide itself to be separated from assay variability. This is one of the clearest reasons to insist on batch-level analytical documentation before designing an experiment.

Innate immunity and host-defence models

Research interest in Innate immunity and host-defence models centres on how Thymosin Alpha-1 10mg behaves at the level of cell-migration, proliferation and viability measurements. Reported findings in this area are most useful when the preparation is fully characterised, since an unquantified purity difference between batches can easily be mistaken for a biological effect. Reproducibility in this line of work depends heavily on the consistency of the starting material across repeats.

Reported Mechanism of Action

Thymosin alpha-1 is reported to act through toll-like receptor signalling on dendritic cells and to enhance T-cell maturation, natural killer cell activity and cytokine responses, shifting the immune balance toward a Th1-type profile. Research typically measures dendritic-cell maturation markers, T-cell proliferation, interferon-gamma release and responses to co-administered antigens.

It is worth noting that mechanistic reports on Thymosin Alpha-1 10mg come from several different model systems – cultured cells, tissue preparations and animal models – and that conclusions drawn in one system are not automatically transferable to another. The synthetic N-acetylated 28-amino-acid peptide (prothymosin alpha fragment) classification describes the chemistry of the material, not a validated clinical action.

Purity, Testing and Certificates of Analysis

In peptide work, an impurity is not just a purity number on a page: co-eluting sequences, residual trifluoroacetate and moisture all alter how a preparation behaves in culture or in an assay. The certificate of analysis records the method used, the retention profile, the observed mass and the final purity figure, giving you a verifiable record rather than an unqualified purity claim.

Independent analysis of this material reports 99% (HPLC-MS verified, third-party tested). The certificate of analysis records the method used, the chromatographic profile, the mass-spectrometric identity confirmation and the final purity value, and it is issued against the specific batch supplied. That distinction matters: an identity confirmation from mass spectrometry establishes that the principal peak corresponds to the expected molecular mass, while the chromatographic purity figure describes how much of the total peak area that principal peak represents. A third element of quality control, which is not visible on a purity number, is the water and salt content of the lyophilised powder – residual moisture and counter-ion content both change the effective concentration of the peptide when the vial is dissolved. If your protocol requires a specific acceptance threshold, verify it against the certificate of analysis for the batch you receive before beginning work, and file that document with your study records so the material can be traced later.

Handling, Storage and Reconstitution

Storing the lyophilised powder

Unreconstituted lyophilised powder should be stored at -20 degrees Celsius, protected from light and kept as dry as possible. After dissolution, store the preparation refrigerated at 2 to 8 degrees Celsius and aliquot it so that freeze-thaw cycling is avoided.

Reconstitution

For dissolution, start with bacteriostatic water. If the peptide is slow to enter solution, a preserved 0.9% benzyl alcohol solution can be used in its place.

To calculate a working concentration, divide the mass of peptide in the vial by the volume of diluent added. For example, a 10mg vial dissolved in 2 mL of diluent gives approximately 5 mg/mL per mL. A convenient shorthand is that a 10mg vial dissolved in 2mL of diluent gives a 5mg/mL stock, while the same vial dissolved in 5mL gives 2mg/mL. Add the diluent slowly down the wall of the vial rather than directing the stream onto the powder, swirl gently instead of shaking, and never vortex a peptide solution: mechanical shear and foaming both encourage aggregation.

Laboratory handling practice

Prepare and handle Thymosin Alpha-1 10mg in an appropriate laboratory environment using clean technique. Work with gloves and eye protection, use dedicated glassware or single-use labware, and label every aliquot with the compound name, concentration, batch number and preparation date. When drawing from a multi-use vial, swab the stopper before and after use and keep the needle small to reduce coreing. Avoid repeated freeze-thaw cycles, because each thaw exposes the peptide to a fresh round of hydrolysis and aggregation; prepare single-use aliquots instead. Dispose of all peptide waste in accordance with your institution’s chemical-waste policy, and record the batch number in your laboratory notebook so that any analytical outlier can be traced back to a specific vial.

Available Sizes and Pricing

Thymosin Alpha-1 10mg is supplied as a single 10mg vial priced at $105.

The vial range reflects the two common research patterns: small vials for titration and pilot work where only a little material is consumed per experiment, and larger vials for repeated runs that benefit from a single, internally consistent stock preparation.

How to Order Thymosin Alpha-1 10mg Online

Orders placed before the daily cut-off are packed the same working day, and every shipment includes the batch-matched certificate of analysis. Browse the full Peptides category listing, or compare other compounds in the same family: LL-37 5mg, ARA-290 16mg, Glutathione.

Protide Health Lab supplies Thymosin Alpha-1 10mg from domestic inventory with same-day dispatch for orders received before the daily cut-off. Each order includes the batch-matched certificate of analysis, and shipment tracking is provided so that delivery can be confirmed. Keep the vial closed until it reaches the laboratory, then store it as described in the handling section above.

Frequently Asked Questions

What is Thymosin Alpha-1 10mg?

Thymosin alpha-1 is a synthetic 28-amino-acid peptide corresponding to the N-terminal fragment of prothymosin alpha, with an acetyl group on the N-terminus It is supplied as a research reagent for in-vitro laboratory investigation, not as a therapeutic product..

What purity is Thymosin Alpha-1 10mg supplied at?

The material is released against independent analytical testing, with a reported purity of 99% (HPLC-MS verified, third-party tested). The certificate of analysis for your specific batch records the method used, the chromatographic profile and the mass-spectrometric identity confirmation, and it ships with the order.

What vial sizes of Thymosin Alpha-1 10mg are available?

Thymosin Alpha-1 10mg is supplied as a single 10mg vial.

How much does Thymosin Alpha-1 10mg cost?

Thymosin Alpha-1 10mg is priced at $105 per vial, and the batch certificate of analysis is included with the order.

What is Thymosin Alpha-1 10mg supplied as?

It is supplied as a lyophilised (freeze-dried) powder in a sealed glass vial. The dry format is the most stable way to ship and store a research peptide, and it keeps the material usable for longer than a pre-dissolved solution would.

How should Thymosin Alpha-1 10mg be stored?

Keep the sealed vial frozen at -20 degrees Celsius, protected from light, until you are ready to use it. After reconstitution, store the solution at 2 to 8 degrees Celsius and use single-use aliquots to avoid repeated freeze-thaw cycling, which accelerates hydrolysis and aggregation.

What diluent should be used to reconstitute Thymosin Alpha-1 10mg?

Bacteriostatic water is the usual choice; a preserved 0.9%% benzyl alcohol solution is a practical alternative when the same vial will be drawn from repeatedly. Add the diluent slowly down the vial wall, swirl gently and never vortex, because mechanical shear promotes aggregation. Divide the vial mass by the volume added to obtain your working concentration.

Is Thymosin Alpha-1 10mg intended for human use?

No. This product is a research chemical supplied for in-vitro laboratory investigation only. It is not intended for human or veterinary use, and it is not a treatment, diagnostic or supplement.

How can I confirm the certificate of analysis for my batch?

The certificate of analysis is matched to the batch number printed on the vial and is included with the shipment. Compare the reported purity and identity data against the acceptance criteria in your protocol and file the document with your study records so the material remains traceable.

Related Research Peptides

If your study design calls for more than one compound, these related products are the ones most often purchased together with Thymosin Alpha-1 10mg.

• LL-37 5mg – synthetic cathelicidin-derived peptide (37 amino acids).
• ARA-290 16mg – synthetic 11-amino-acid non-haematopoietic erythropoietin-derived peptide.
• Glutathione – endogenous tripeptide (gamma-glutamyl-cysteinyl-glycine).
• KPV 10mg – synthetic tripeptide (Lys-Pro-Val), C-terminal fragment of alpha-MSH.

The complete research catalogue is available on the https://protidehealthlab.store/shop/ page. If you are unsure which vial size fits your protocol, order the smaller size first, confirm that the material meets your acceptance criteria against the certificate of analysis, and scale up once the preparation has performed as expected. Every listing shows the analytical documentation for the batch, so the material can be evaluated on evidence before it is ordered.

References and Further Reading

The links below point to publicly indexed literature and reference resources relevant to this compound class. They are provided so that the mechanistic summaries above can be traced to their sources. Access to full text depends on the subscription arrangements of your institution.

• Peer-reviewed literature indexed in PubMed (PMID 11057600)
• Peer-reviewed literature indexed in PubMed (PMID 24979162)
• PubMed – biomedical literature database maintained by the National Library of Medicine
• National Institutes of Health – public research and health information resources

Research Use Only Disclaimer

This product is sold strictly as a chemical reference material for in-vitro laboratory research and is not a drug, supplement, cosmetic or food. It must not be administered to humans or animals, must not be used for diagnostic or therapeutic purposes, and must be handled only by qualified personnel in an appropriate laboratory setting. Statements describing areas of scientific interest are summaries of published research literature and do not constitute claims of efficacy, safety or intended use. By purchasing, the buyer confirms that they are a qualified researcher and that the material will be used lawfully within an institutional or laboratory research context.